- Home
- KLXE vs DXR Comparison
KLXE vs DXR Comparison
Compare KLXE & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- DXR
- Stock Information
- Founded
- KLXE 2018
- DXR 1970
- Country
- KLXE United States
- DXR United States
- Employees
- KLXE N/A
- DXR N/A
- Industry
- KLXE Oilfield Services/Equipment
- DXR Medical/Dental Instruments
- Sector
- KLXE Energy
- DXR Health Care
- Exchange
- KLXE Nasdaq
- DXR Nasdaq
- Market Cap
- KLXE 35.8M
- DXR 36.4M
- IPO Year
- KLXE N/A
- DXR N/A
- Fundamental
- Price
- KLXE $2.23
- DXR $7.30
- Analyst Decision
- KLXE Hold
- DXR Strong Buy
- Analyst Count
- KLXE 1
- DXR 1
- Target Price
- KLXE $4.50
- DXR $25.00
- AVG Volume (30 Days)
- KLXE 173.4K
- DXR 4.8K
- Earning Date
- KLXE 05-08-2025
- DXR 01-01-0001
- Dividend Yield
- KLXE N/A
- DXR N/A
- EPS Growth
- KLXE N/A
- DXR 86.16
- EPS
- KLXE N/A
- DXR 0.11
- Revenue
- KLXE $688,600,000.00
- DXR $119,714.00
- Revenue This Year
- KLXE $0.22
- DXR N/A
- Revenue Next Year
- KLXE $4.89
- DXR N/A
- P/E Ratio
- KLXE N/A
- DXR $66.24
- Revenue Growth
- KLXE N/A
- DXR N/A
- 52 Week Low
- KLXE $1.51
- DXR $6.55
- 52 Week High
- KLXE $7.66
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- KLXE 49.10
- DXR 44.11
- Support Level
- KLXE $1.80
- DXR $7.19
- Resistance Level
- KLXE $2.42
- DXR $7.74
- Average True Range (ATR)
- KLXE 0.24
- DXR 0.41
- MACD
- KLXE 0.09
- DXR -0.02
- Stochastic Oscillator
- KLXE 68.55
- DXR 27.40
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.